Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial-Reference-Cited by-同舟云学术

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

Published:2012-01 Issue:1 Volume:11 Page:33-41
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Comi Giancarlo,De Stefano Nicola,Freedman Mark S,Barkhof Frederik,Polman Chris H,Uitdehaag Bernard MJ,Casset-Semanaz Florence,Hennessy Brian,Moraga Margaretha Stam,Rocak Sanda,Stubinski Bettina,Kappos Ludwig

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference24 articles.

1. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis;Miller;Lancet Neurol,2005

2. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability;Weinshenker;Brain,1989

3. Relapses and progression of disability in multiple sclerosis;Confavreux;N Engl J Med,2000

4. Problems of experimental trials of therapy in multiple sclerosis;Schumacher;Ann N Y Acad Sci,1965

5. New diagnostic criteria for multiple sclerosis: guidelines for research protocols;Poser;Ann Neurol,1983

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines;Multiple Sclerosis and Related Disorders;2024-03

2. Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?;Multiple Sclerosis Journal;2024-02-27

3. Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives;Neurology and Therapy;2024-01-11

4. Comorbilidades en la esclerosis múltiple y su influencia en la elección del tratamiento;Revista de Neurología;2024

5. Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China;Therapeutic Advances in Neurological Disorders;2024-01